Arthur Erdman, PhD
ARTHUR ERDMAN, PhD
Arthur G. Erdman, PhD, is the Richard C. Jordan Professor and a Morse Alumni Distinguished Teaching Professor of Mechanical Engineering at the University of Minnesota, specializing in mechanical design, bioengineering and product design. In July 2007 he was selected as the Director of the Earl E. Bakken Medical Devices Center at the U of M. He received his BS degree at Rutgers University, his MS and PhD at RPI. Dr. Erdman has published over 350 technical papers, 3 books, holds over 40 patents, and shares with his former students 9 Best Paper Awards at international conferences.
Dr. Erdman currently has a number of ongoing projects of which many are related to biomedical engineering and medical device design. He led the effort to create LINCAGES, a mechanism software design package that has been use worldwide. Dr. Erdman has had research collaborations with faculty in Ophthalmology, Neuroscience, Epidemiology, Orthopedics, Surgery, Dentistry, Otolaryngology and Sport Biomechanics. He has consulted at over 50 companies in mechanical and product design, including Xerox, 3M, Andersen Windows, Proctor and Gamble, HP, Rollerblade, Sulzer Medica and Yamaha. He has received a number of awards including ASME Machine Design Award and the ASME Outstanding Design Educator Award. Erdman is a Fellow of ASME and a Founding Fellow of AIMBE. He has been the Chair of the Design of Medical Devices Conference since it's inception in 2001. The DMD Conference is held on the University of Minnesota campus each April.
Matthew Johnson, PhD
MATTHEW JOHNSON, PhD
We are honored to have Dr. Matthew Johnson, Associate Professor, Department of Biomedical Engineering, University of Minnesota as Associate Director of the Earl E. Bakken Medical Devices Center, University of Minnesota.
Matthew D. Johnson, PhD, is an Associate Professor of Biomedical Engineering and Scholar in the Institute for Translational Neuroscience at the University of Minnesota. He is a former recipient of a McKnight Land-Grant Professorship at the University of Minnesota (2015-2017). He received his BS degree in engineering sciences from Harvard University, and his MS and PhD in biomedical engineering from the University of Michigan. He then completed a post-doctoral fellowship (NIH-NRSA) at the Cleveland Clinic. Dr. Johnson's expertise is in the area of translational neural engineering with specific research interests in developing medical devices and software tools for treating neurological disorders. His research group is actively funded by the NIH and NSF, and collaborates with a broad range of medical device companies through research contracts and SBIR grants. Dr. Johnson has also been the Contributed Papers Chair/Co-Chair of the DMD Conference since 2013.
Dr. Johnson's research lab - the Neuromodulation Research and Technology Laboratory - focuses on innovating neuromodulation technologies to improve quality of life for people with neurological disorders. Deep brain stimulation (DBS) is one such technology, which has helped numerous people living with Parkinson's disease, dystonia, and essential tremor reclaim control over their motor function.
Dr Johnson will be an integral part of the Bakken MDC team with expertise in SBIR and STTR grant applications, NIH and NSF proposals and will be an asset for the Innovation Fellows team.
Angela Panoskaltsis-Mortari, PhD
ANGELA PANOSKALTSIS-MORTARI, PhD
We are honored to officially welcome Dr. Angela Panoskaltsis-Mortari, Professor, Department of Medicine, Division of Pulmonary, Allergy, Critical Care and Sleep, University of Minnesota as the new Associate Director of the Earl E. Bakken Medical Devices Center, University of Minnesota.
Dr. Angela Panoskaltsis-Mortari is Professor and Vice Chair for Research in the Department of Pediatrics, Division of Blood & Marrow Transplantation, and Professor of Medicine, Division of Pulmonary, Allergy, Critical Care and Sleep at the University of Minnesota. She was originally trained as an Immunologist (UWO, Canada) with post-doctoral training in Pathology (UAB). With over 25 years of experience in animal models of stem cell transplant, lung injury, and mesenchymal stem/stromal cell therapy, Dr. Panoskaltsis-Mortari’s work has evolved into the bioengineering field. She is recognized as one of the thought leaders in lung bioengineering, and has licensed IP. Her laboratory research team focuses upon 3 major themes: 1) bioengineering the lung using adult stem cells and decellularized whole lung scaffolds while incorporating evaluation of novel devices; 2) bioengineering tissues such as trachea and esophagus using 3D bioprinting and customized hydrogels and bioreactors; 3) 3D bioprinting of cancer models. Her goal is to realize the potential of regenerative medicine by converging the fields of stem cell biology, mechanical & biomedical engineering, biomaterials, physiology and surgery to bioengineer autologous tissues/organs for transplant using a patient's own cells that would not be rejected by their immune system.
Dr. Panoskaltsis-Mortari established and directs the 3D Bioprinting Facility at the University of Minnesota, and developed the first full-semester course in the country dedicated to 3D Bioprinting and how it interfaces with other fields. She also directs the UMN Cytokine Reference Laboratory (a CLIA-licensed facility) and is board-certified by the American Board of Medical Laboratory Immunology. She is a Fellow of the American Institute for Medical & Biological Engineering (AIMBE). Each year, she organizes the “Manufacturing Needs for Biofabrication of Engineered Tissues & Organs” meeting as a satellite to the BMDC’s DMD conference and collaborates with ARMI-BioFabUSA. She is funded by the NIH, has mentored many post-docs, MD trainees, graduate students and undergrads in various training programs, and is Associate Director of the CTSI TL1/TRACT training program.